302 related articles for article (PubMed ID: 20515425)
1. The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis.
Inam S; Vucic S; Brodaty NE; Zoing MC; Kiernan MC
Amyotroph Lateral Scler; 2010 Dec; 11(6):558-61. PubMed ID: 20515425
[TBL] [Abstract][Full Text] [Related]
2. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
3. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
4. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
5. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
6. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
7. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
8. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
9. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
[TBL] [Abstract][Full Text] [Related]
10. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
11. Mirror movements in amyotrophic lateral sclerosis.
Wittstock M; Meister S; Walter U; Benecke R; Wolters A
Amyotroph Lateral Scler; 2011 Nov; 12(6):393-7. PubMed ID: 21554031
[TBL] [Abstract][Full Text] [Related]
12. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
Pinto S; Pinto A; De Carvalho M
Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models.
Cheah BC; Vucic S; Krishnan AV; Boland RA; Kiernan MC
Amyotroph Lateral Scler; 2011 Jan; 12(1):33-8. PubMed ID: 21271790
[TBL] [Abstract][Full Text] [Related]
14. Respiratory function in amyotrophic lateral sclerosis.
Iłzecka J; Stelmasiak Z; Balicka G
Neurol Sci; 2003 Nov; 24(4):288-9. PubMed ID: 14658052
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
16. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
17. A role for functional classification in the early identification of prognostic factors in ALS.
Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
[TBL] [Abstract][Full Text] [Related]
18. Isolated bulbar phenotype of amyotrophic lateral sclerosis.
Burrell JR; Vucic S; Kiernan MC
Amyotroph Lateral Scler; 2011 Jul; 12(4):283-9. PubMed ID: 21702735
[TBL] [Abstract][Full Text] [Related]
19. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis.
Keizman D; Rogowski O; Berliner S; Ish-Shalom M; Maimon N; Nefussy B; Artamonov I; Drory VE
Acta Neurol Scand; 2009 Jun; 119(6):383-9. PubMed ID: 18976328
[TBL] [Abstract][Full Text] [Related]
20. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
